Back

Select your region

Arrange a consultation about stem cells

Learn more

List of
transplantations

List of uses for stem cells approved by the FamiCord Group’s laboratories:

Image
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
6301 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6302 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6303 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6304 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6305 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 63
6306 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 55
6307 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
6308 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
6309 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 62
6310 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6311 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 55
6312 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6313 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6314 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 52
6315 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 61
6316 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
6317 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 73
6318 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 42
6319 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 60
6320 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6321 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
6322 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 66
6323 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 65
6324 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 51
6325 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 69
6326 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 50
6327 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 67
6328 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 50
6329 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 64
6330 Apheresis Autologous Multiple Myeloma Hematology 2018 Standard Therapy Germany 56
6331 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 74
6332 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6333 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 72
6334 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
6335 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 50
6336 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 62
6337 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 68
6338 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 54
6339 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6340 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 22
6341 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 64
6342 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 77
6343 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 66
6344 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 60
6345 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 68
6346 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 39
6347 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 62
6348 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 56
6349 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
6350 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
6351 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 27
6352 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 70
6353 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 39
6354 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 71
6355 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 32
6356 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
6357 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
6358 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
6359 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6360 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 65
6361 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 66
6362 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 48
6363 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 60
6364 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 57
6365 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 46
6366 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 49
6367 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 4
6368 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6369 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 69
6370 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
6371 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 8
6372 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 58
6373 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 61
6374 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6375 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 61
6376 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 65
6377 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 57
6378 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 27
6379 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2018 Standard Therapy Poland 61
6380 Apheresis Allogeneic Myelodysplastic Syndrome Refractory Anemia With Blast Proliferation Ii Hematology 2018 Standard Therapy Germany 57
6381 Apheresis Allogeneic Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Germany 65
6382 Apheresis Allogeneic Myelodysplastic Syndrome; Acute Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 74
6383 Apheresis Allogeneic Myelodysplastic Syndrome; Myeloproliferative Neoplasms Hematology 2018 Standard Therapy Germany 62
6384 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 49
6385 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 60
6386 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 56
6387 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 58
6388 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 64
6389 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 68
6390 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 72
6391 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 53
6392 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 56
6393 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 57
6394 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 55
6395 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 52
6396 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2018 Standard Therapy Poland 61
6397 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 69
6398 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 70
6399 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 38
6400 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 22